|
Income Taxes - Deferred Tax Assets and Liabilities (Detail) (USD $)
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|---|---|---|
| Deferred tax assets: | ||
| Net operating loss carryforwards | $ 22,346,862 | $ 8,329,939 |
| Accrued expenses | 215,865 | |
| Accrued employee benefits | 377,049 | 282,268 |
| Capitalized research and development costs | 31,891 | 27,516 |
| Research and development credit | 1,874,939 | 1,928,714 |
| Nonqualified stock options | 53,686 | |
| Deferred revenue | 643,669 | |
| Deferred tax liabilities: | ||
| Depreciation | 102,916 | 130,017 |
| Net deferred tax asset | 24,787,343 | 11,557,988 |
| Valuation allowance | (24,787,343) | (11,557,988) |
| Net deferred tax asset |